ONS

Cancer Basics (Third Edition)

kristinag — Tue, 09 Aug 2022 15:14:17 +0000

Cancer Basics (Third Edition) kristinag Tue, 08/09/2022 - 11:14

Overview

The Cancer Basics book series was developed to offer fundamentals of cancer and its treatment to recently graduated and experienced nurses looking for professional growth and knowledge in their oncology specialty. This third edition of Cancer Basics addresses the same fundamentals of cancer and its treatment as previous editions. It has added symptom management and survivorship basics using the most state-of-the-science and evidence-based content for a more comprehensive review. All content has been updated to provide a more reader- and learner-friendly product that will appeal to a broader audience of oncology and non-oncology professionals.

New chapters have been included on immunotherapy, adoptive cellular therapy, infusion-related adverse events, and caregiver and family education. Each chapter features key points and study questions to aid the learner in identifying essential concepts. These questions and their associated rationale can be used as a study guide for preparation for the oncology certified nurse (OCN^®) examination.

In 2023, Cancer Basics received a Grand Award in the public health concerns category from the Awards for Publication Excellence competition.

Edited By: Julia A. Eggert, Katherine L. Byar, & Lisa S. Parks

ISBN: 978-1-63593-051-1

Published By: Oncology Nursing Society

Pages: 584

Interventions to Support Adherence to Oral Anticancer Medications: Systematic Review and Meta-Analysis

onsdrupaladmin — Mon, 18 Jul 2022 04:00:00 +0000

Interventions to Support Adherence to Oral Anticancer Medications: Systematic Review and Meta-Analysis onsdrupaladmin Mon, 07/18/2022 - 00:00

Problem Identification: This systematic review compared the efficacy of interventions to usual care on adherence to oral anticancer regimens.

Literature Search: Embase®, PubMed®, and CINAHL® were searched for eligible comparative studies published between January 2000 and May 2021. Outcomes of interest included adherence, cancer-related morbidity, quality of life, patient satisfaction, and other patient-specific outcomes.

Data Evaluation: Reviewers assessed risk of bias using the Cochrane Risk of Bias 2 tool and Risk of Bias in Nonrandomized Studies of Interventions. Certainty of evidence was assessed using the GRADE framework.

Synthesis: Risk assessment, ongoing or periodic assessment, proactive follow-up, motivational interviewing, or structured programs may improve adherence. Education or coaching interventions may improve or have little to no effect on adherence. Technological interventions may improve adherence, but interactive compared to noninteractive technology may have little to no effect.

Implications for Research: As more cancer treatments move to oral formulations, work remains to identify the most effective interventions to support people receiving oral anticancer regimens.

Supplementary material can be found at https://bit.ly/3K0OChs

oral anticancer medications, adherence, technology, risk assessment

1 13

Advance Print Exclusive

Journal Articles

Disable Ad?

Off

Show last on Global Search

ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications

onsdrupaladmin — Mon, 18 Jul 2022 04:00:00 +0000

ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications onsdrupaladmin Mon, 07/18/2022 - 00:00

Purpose: This evidence-based guideline intends to support patients, clinicians, and others regarding interventions and processes to support patient adherence to oral anticancer medications (OAMs).

Methodologic Approach: A panel of healthcare professionals and patient representatives developed a clinical practice guideline to support patients taking OAMs. GRADE (Grading of Recommendations Assessment, Development, and Evaluation) methodology and criteria for trustworthy guidelines were followed. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. A quantitative or narrative synthesis of the evidence was completed. Certainty of the evidence was assessed using GRADE.

Findings: The panel agreed on recommendations and suggested an adherence risk assessment, education addressing adherence, ongoing assessment, proactive follow-up, coaching, and motivational interviewing in addition to usual care. The panel suggested the implementation of a structured OAM program.

Implications for Nursing: As cancer treatment shifts from clinic to home settings, interventions and programs to support patients on OAMs are needed.

Supplementary material can be found at https://bit.ly/3OmKewx

guideline, oral anticancer medications, medication adherence, oncology nursing

1 17

Advance Print Exclusive

Journal Articles

Disable Ad?

Off

Show last on Global Search

Supplementary Material for ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications

onsdrupaladmin — Mon, 18 Jul 2022 04:00:00 +0000

Supplementary Material for ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications onsdrupaladmin Mon, 07/18/2022 - 00:00

Table 1. Study characteristics of additional studies for PICO 1
Table 2. Evidence Profile for PICO 1
Table 3. Evidence Profile for PICO 2
Table 4. Evidence Profile for PICO 3
Table 5. Evidence Profile for PICO 4
Table 6. Evidence Profile for PICO 5
Table 7. Evidence Profile for PICO 6
Table 8. Evidence Profile for PICO 7
Table 9. Evidence Profile for PICO 8
Table 10. Evidence Profile for PICO 9

guideline, oral anticancer medications, medication adherence, oncology nursing

1 44

Advance Print Exclusive

Journal Articles

Disable Ad?

Off

Show last on Global Search

Supplementary Material for Interventions to Support Adherence to Oral Anticancer Medications: Systematic Review and Meta-Analysis

onsdrupaladmin — Mon, 18 Jul 2022 04:00:00 +0000

Supplementary Material for Interventions to Support Adherence to Oral Anticancer Medications: Systematic Review and Meta-Analysis onsdrupaladmin Mon, 07/18/2022 - 00:00

Table 1. Taxonomy for Critical Outcomes
Search Strategies for PICO 1–4
Search Strategies for PICO 5–6
Search Strategies for PICO 7–8
Search Strategies for PICO 9
Figure 1. PRISMA Flow Diagram for PICO 1–4
Figure 2. PRISMA Flow Diagram for PICO 5–6
Figure 3. PRISMA Flow Diagram for PICO 7–8
Figure 4. PRISMA Flow Diagram for PICO 9
Table 2. Studies Not Included in Quantitative Syntheses
Table 3. Characteristics of PICO 1 Studies
Table 4. Characteristics of PICO 2 Studies
Table 5. Characteristics of PICO 3 Studies
Table 6. Characteristics of PICO 4 Studies
Table 7. Characteristics of PICO 5 Studies
Table 8. Characteristics of PICO 6 Studies
Table 9. Characteristics of PICO 7 Studies
Table 10. Characteristics of PICO 8 Studies
Table 11. Characteristics of PICO 9 Studies
Table 12. Risk of Bias for PICO 1 Randomized Studies
Table 13. Risk of Bias for PICO 2 Studies Non-Randomized Studies
Table 14. Risk of Bias for PICO 2 Studies Randomized Studies
Table 15. Risk of Bias for PICO 3 Non-Randomized Studies
Table 16. Risk of Bias for PICO 3 Randomized Studies
Table 17. Risk of Bias for PICO 4 Non-Randomized Studies
Table 18. Risk of Bias for PICO 4 Randomized Studies
Table 19. Risk of Bias for PICO 5 Non-Randomized Studies
Table 20. Risk of Bias for PICO 5 Randomized Studies
Table 21. Risk of Bias for PICO 6 Non-Randomized Studies
Table 22. Risk of Bias for PICO 6 Randomized Studies
Table 23. Risk of Bias for PICO 7 Non-Randomized Studies
Table 24. Risk of Bias for PICO 7 Randomized Studies
Table 25. Risk of Bias for PICO 8 Randomized Studies
Table 26. Risk of Bias for PICO 9 Non-Randomized Studies
Table 27. Evidence Profile for PICO 1
Table 28. Evidence Profile for PICO 2
Table 29. Evidence Profile for PICO 3
Table 30. Evidence Profile for PICO 4
Table 31. Evidence Profile for PICO 5
Table 32. Evidence Profile for PICO 6
Table 33. Evidence Profile for PICO 7
Table 34. Evidence Profile for PICO 8
Table 35. Evidence Profile for PICO 9
Figures 5–19. Forest Plots

oral anticancer agents, adherence, technology, risk assessment

1 13

Advance Print Exclusive

Journal Articles

Disable Ad?

Off

Show last on Global Search

Domains of Structured Oral Anticancer Medication Programs: A Scoping Review

onsdrupaladmin — Fri, 01 Jul 2022 04:00:00 +0000

Domains of Structured Oral Anticancer Medication Programs: A Scoping Review onsdrupaladmin Fri, 07/01/2022 - 00:00

Problem Identification: An interprofessional approach is necessary to support the multifactorial process of patient adherence to oral anticancer medications (OAMs). This scoping review aims to identify structured OAM programs in published literature, identify components within studies, and propose a framework for institutions developing or maintaining OAM programs.

Literature Search: Embase^®, PubMed^®, and CINAHL^® databases were searched for studies published between January 2000 and April 2021.

Data Evaluation: Two reviewers screened studies and extracted data. Characteristics and specific domains of the OAM programs were captured. Key components of the programs were identified, and a framework was created to guide program development.

Synthesis: Components identified among the 21 studies were education; counseling; follow-up; dedicated clinician contact; adverse event and toxicity monitoring; adherence monitoring; drug procurement, delivery, and supply; patient- and system-level cost reduction; information technology; and risk assessment.

Implications for Research: Based on the findings, a framework for building and evaluating OAM adherence programs is proposed. Future studies should evaluate the reliability and validity of this framework because further testing may lead to the development of additional components.

Supplementary material can be found at https://bit.ly/3L2trN8

oral anticancer medications, oncology care, cancer nursing, medication adherence, scoping review

1 11

Advance Print Exclusive

Journal Articles

Disable Ad?

Off

Show last on Global Search

Supplementary Material for Domains of Structured Oral Anticancer Medication Programs: A Scoping Review

onsdrupaladmin — Fri, 01 Jul 2022 04:00:00 +0000

Supplementary Material for Domains of Structured Oral Anticancer Medication Programs: A Scoping Review onsdrupaladmin Fri, 07/01/2022 - 00:00

Search strategies
Study characteristics
Oral anticancer medication program components

oral anticancer medications, oncology care, cancer nursing, medication adherence, scoping review

1 23

Advance Print Exclusive

Journal Articles

Disable Ad?

Off

Show last on Global Search

Website Upgrade Scheduled for June 11

onsdrupaladmin — Mon, 06 Jun 2022 04:00:00 +0000

Website Upgrade Scheduled for June 11 onsdrupaladmin Mon, 06/06/2022 - 00:00

Starting at 8 am ET on Saturday, June 11th, ONF.ons.org, CJON.ons.org, and eBooks.ons.org content will be transitioned to ONS.org. Once the upgrade is complete, all journal and ebook content will be available at ONS.org.

Journal Articles

Disable Ad?

Off

Show last on Global Search

Robin Atkins

onsdrupaladmin — Fri, 20 May 2022 17:57:11 +0000

Robin Atkins onsdrupaladmin Fri, 05/20/2022 - 13:57

First Name

Robin

Last Name

Atkins

Degrees

RN, OCN

Organization Name

Virginia Oncology Associates

Sarah Freylersythe

onsdrupaladmin — Fri, 20 May 2022 17:42:26 +0000

Sarah Freylersythe onsdrupaladmin Fri, 05/20/2022 - 13:42

First Name

Sarah

Last Name

Freylersythe

Degrees

Organization Name

University of Arizona

ONS

Cancer Basics (Third Edition)

Overview

Interventions to Support Adherence to Oral Anticancer Medications: Systematic Review and Meta-Analysis

Disable Ad?

Show last on Global Search

ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications

Disable Ad?

Show last on Global Search

Supplementary Material for ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications

Table of Contents

Disable Ad?

Show last on Global Search

Supplementary Material for Interventions to Support Adherence to Oral Anticancer Medications: Systematic Review and Meta-Analysis

Table of Contents

Disable Ad?

Show last on Global Search

Domains of Structured Oral Anticancer Medication Programs: A Scoping Review

Disable Ad?

Show last on Global Search

Supplementary Material for Domains of Structured Oral Anticancer Medication Programs: A Scoping Review

Table of Contents

Disable Ad?

Show last on Global Search

Website Upgrade Scheduled for June 11

Disable Ad?

Show last on Global Search

Robin Atkins

First Name

Last Name

Degrees

Organization Name

Sarah Freylersythe

First Name

Last Name

Degrees

Organization Name